Receipt of Notice under Section 18 of MSMED Act, 2006
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Coral Laboratories Ltd has received a legal notice under Section 18 of the Micro, Small and Medium Enterprises Development (MSMED) Act, 2006. This typically occurs when an MSME supplier files a complaint regarding delayed payments or disputes over dues. Section 18 of the MSMED Act provides a statutory mechanism for MSME suppliers to resolve payment-related grievances against buyers. The company has disclosed receipt of this notice to the stock exchange as a regulatory requirement. The specific details of the dispute amount or counterparty are not visible in the available document content.
This indicates a potential payment dispute with an MSME supplier. If the dispute is upheld, the company may face financial liability including delayed payment interest as mandated under MSMED Act. It does not directly impact stock operations but signals potential contingent liability.